Abstract
Introduction: Preclinical studies support investigation of focused ultrasound for breakdown of cerebral pathologies in neurodegenerative conditions including Alzheimer's disease (AD) and Parkinson's disease (PD). Methods: A focused transcranial Doppler device with probes (2 MHz, 520 mW/cm2) affixed bilaterally was used to target the hippocampus (AD) or substantia nigra (PD) with functional magnetic resonance imaging navigation for enhanced plaque removal. A total of 22 patients (n = 11 AD, n = 11 PD) underwent 8 consecutive, weekly, 1-hour treatments wherein sleep was encouraged naturally or pharmacologically. Cognitive and motor functioning assessment was carried out using standardized evaluations at baseline and conclusion. Results: Of all, 62.5% of patients had one or more improved cognitive scores without data incongruence, 87% had stable or improved fine motor scores, and 87.5% had stable or improved gross motor scores. No adverse events were reported. Discussion: The safety of focused transcranial Doppler and possible enhancement in patient functioning were suggested by outcome data.
| Original language | English |
|---|---|
| Pages (from-to) | 374-381 |
| Number of pages | 8 |
| Journal | Alzheimer's and Dementia: Translational Research and Clinical Interventions |
| Volume | 5 |
| DOIs | |
| State | Published - 2019 |
Keywords
- ASL
- Alzheimer's
- Cognition
- Dementia
- Parkinson's
- Sleep
- Ultrasound
Fingerprint
Dive into the research topics of 'Focused transcranial ultrasound for treatment of neurodegenerative dementia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver